EATRIS joins as a partner the Biomarker Commercialization (BiC) project
The biomarkers’ discovery area is increasing importance in industry and research as it is creating new diagnostic and therapeutic areas as well as it could be the basis for new innovative drivers for both researchers, enterprises and SMEs. According to “Biomarkers Market – Global Forecast to 2021” the global biomarkers market expects to reach a market value of $53.3 billion by 2021 of which healthcare and R&D expenditure are the key growth drivers.
These challenges have paved the way for the Biomarker Commercialization (BIC) project, an Interreg funded project, led by a consortium of eight partners from the Baltic Sea Region.
BIC project aims to develop a set of tools to support and to overcome the issues in the various phases of the commercialization process of biomarkers. The BIC Commercialization Toolset will be made free on the project’s website at the end of summer 2020. BIC project will be extended until June 2021 and EATRIS joined as a partner. EATRIS will support further the uptake of the tool through targeted dissemination at its member institutions, especially through its links to the Technology Transfer Offices.
The objectives of BIC consortium are to create:
• a biomarker development tool for researchers
• a screening and selection guide for TTOs
• a framework for technology translation into the clinical setting
• new business model templates
• a biomarker platform with access to the tools and technology presentations for matchmaking
BIC Webinar series
The BIC consortium is organising a series of webinars around the biomarker commercialization process. A recording of the webinar is available on the project’s webpage. The next webinar is scheduled for August 26 and its focus is on European IVD Regulation and the regulatory requirements for biomarker development and commercialization with a speaker from the Finnish Medicines Agency FIMEA. You can register for the webinar here.
The project’s budget is EUR 2.55 million and is co-financed by the European Regional Development Fund through the Interreg Baltic Sea Region Programme with EUR 1.96 million.